NCT00011986 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 864
- group Id
- BG001
- value
- 864
- group Id
- BG002
- value
- 862
- group Id
- BG003
- value
- 861
- group Id
- BG004
- value
- 861
- group Id
- BG005
- value
- 4312
- units
- Participants
- groups
- description
- Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles
- id
- BG000
- title
- Carbo/Taxol
- description
- Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Gemcitabine 800 mg/m2/dIV on days 1 and 8 x 8 cycles
- id
- BG001
- title
- Carbo/Taxol/Gemcitabine
- description
- Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Doxil 30 mg/m2 IV every other cycle on day 1 x 8 cycles
- id
- BG002
- title
- Carbo/Taxol/Doxil
- description
- Topotecan 1.25 mg/m2/dIV days 1-3 plus Carboplatin AUC 5 IV on day 3 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles
- id
- BG003
- title
- Carbo/Topotecan - Carbo/Taxol
- description
- Gemcitabine 1000 mg/m2/dIV on days 1 and 8 plus Carboplatin AUC 6 IV on day 8 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles
- id
- BG004
- title
- Carbo/Gemcitabine - Carbo/Taxol
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.1
- value
- 57.8
- group Id
- BG001
- spread
- 10.8
- value
- 58.8
- group Id
- BG002
- spread
- 11.1
- value
- 59.0
- group Id
- BG003
- spread
- 11.0
- value
- 58.2
- group Id
- BG004
- spread
- 10.7
- value
- 58.9
- group Id
- BG005
- spread
- 10.9
- value
- 58.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 864
- group Id
- BG001
- value
- 864
- group Id
- BG002
- value
- 862
- group Id
- BG003
- value
- 861
- group Id
- BG004
- value
- 861
- group Id
- BG005
- value
- 4312
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 724
- group Id
- BG001
- value
- 749
- group Id
- BG002
- value
- 743
- group Id
- BG003
- value
- 744
- group Id
- BG004
- value
- 721
- group Id
- BG005
- value
- 3681
- title
- Stage III:see description for details
- categories
- measurements
- group Id
- BG000
- value
- 140
- group Id
- BG001
- value
- 115
- group Id
- BG002
- value
- 119
- group Id
- BG003
- value
- 117
- group Id
- BG004
- value
- 140
- group Id
- BG005
- value
- 631
- title
- Stage IV:see description for details
- description
- FIGO Staging Classification: 1985. Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum. Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV.
- param Type
- NUMBER
- title
- International Federation of Gynecology and Obstetrics (FIGO) Stage
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 748
- group Id
- BG001
- value
- 752
- group Id
- BG002
- value
- 737
- group Id
- BG003
- value
- 752
- group Id
- BG004
- value
- 751
- group Id
- BG005
- value
- 3740
- title
- Ovary
- categories
- measurements
- group Id
- BG000
- value
- 116
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 125
- group Id
- BG003
- value
- 109
- group Id
- BG004
- value
- 110
- group Id
- BG005
- value
- 572
- title
- Peritoneum
- param Type
- NUMBER
- title
- Primary Site of Disease
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 197
- group Id
- BG001
- value
- 218
- group Id
- BG002
- value
- 206
- group Id
- BG003
- value
- 220
- group Id
- BG004
- value
- 203
- group Id
- BG005
- value
- 1044
- title
- Microscopic only
- categories
- measurements
- group Id
- BG000
- value
- 404
- group Id
- BG001
- value
- 384
- group Id
- BG002
- value
- 405
- group Id
- BG003
- value
- 358
- group Id
- BG004
- value
- 398
- group Id
- BG005
- value
- 1949
- title
- ≤ 1 cm gross disease
- categories
- measurements
- group Id
- BG000
- value
- 263
- group Id
- BG001
- value
- 262
- group Id
- BG002
- value
- 251
- group Id
- BG003
- value
- 283
- group Id
- BG004
- value
- 260
- group Id
- BG005
- value
- 1319
- title
- > 1 cm gross disease
- param Type
- NUMBER
- title
- Size of Residual Disease
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 864
- group Id
- BG001
- value
- 864
- group Id
- BG002
- value
- 862
- group Id
- BG003
- value
- 861
- group Id
- BG004
- value
- 861
- group Id
- BG005
- value
- 4312
- units
- Participants
- groups
- description
- Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles
- id
- BG000
- title
- Carbo/Taxol
- description
- Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Gemcitabine 800 mg/m2/dIV on days 1 and 8 x 8 cycles
- id
- BG001
- title
- Carbo/Taxol/Gemcitabine
- description
- Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Doxil 30 mg/m2 IV every other cycle on day 1 x 8 cycles
- id
- BG002
- title
- Carbo/Taxol/Doxil
- description
- Topotecan 1.25 mg/m2/dIV days 1-3 plus Carboplatin AUC 5 IV on day 3 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles
- id
- BG003
- title
- Carbo/Topotecan - Carbo/Taxol
- description
- Gemcitabine 1000 mg/m2/dIV on days 1 and 8 plus Carboplatin AUC 6 IV on day 8 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles
- id
- BG004
- title
- Carbo/Gemcitabine - Carbo/Taxol
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.1
- value
- 57.8
- group Id
- BG001
- spread
- 10.8
- value
- 58.8
- group Id
- BG002
- spread
- 11.1
- value
- 59.0
- group Id
- BG003
- spread
- 11.0
- value
- 58.2
- group Id
- BG004
- spread
- 10.7
- value
- 58.9
- group Id
- BG005
- spread
- 10.9
- value
- 58.6
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 864
- group Id
- BG001
- value
- 864
- group Id
- BG002
- value
- 862
- group Id
- BG003
- value
- 861
- group Id
- BG004
- value
- 861
- group Id
- BG005
- value
- 4312
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 724
- group Id
- BG001
- value
- 749
- group Id
- BG002
- value
- 743
- group Id
- BG003
- value
- 744
- group Id
- BG004
- value
- 721
- group Id
- BG005
- value
- 3681
- title
- Stage III:see description for details
- categories
- measurements
- group Id
- BG000
- value
- 140
- group Id
- BG001
- value
- 115
- group Id
- BG002
- value
- 119
- group Id
- BG003
- value
- 117
- group Id
- BG004
- value
- 140
- group Id
- BG005
- value
- 631
- title
- Stage IV:see description for details
- description
- FIGO Staging Classification: 1985. Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum. Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV.
- param Type
- NUMBER
- title
- International Federation of Gynecology and Obstetrics (FIGO) Stage
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 748
- group Id
- BG001
- value
- 752
- group Id
- BG002
- value
- 737
- group Id
- BG003
- value
- 752
- group Id
- BG004
- value
- 751
- group Id
- BG005
- value
- 3740
- title
- Ovary
- categories
- measurements
- group Id
- BG000
- value
- 116
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 125
- group Id
- BG003
- value
- 109
- group Id
- BG004
- value
- 110
- group Id
- BG005
- value
- 572
- title
- Peritoneum
- param Type
- NUMBER
- title
- Primary Site of Disease
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 197
- group Id
- BG001
- value
- 218
- group Id
- BG002
- value
- 206
- group Id
- BG003
- value
- 220
- group Id
- BG004
- value
- 203
- group Id
- BG005
- value
- 1044
- title
- Microscopic only
- categories
- measurements
- group Id
- BG000
- value
- 404
- group Id
- BG001
- value
- 384
- group Id
- BG002
- value
- 405
- group Id
- BG003
- value
- 358
- group Id
- BG004
- value
- 398
- group Id
- BG005
- value
- 1949
- title
- ≤ 1 cm gross disease
- categories
- measurements
- group Id
- BG000
- value
- 263
- group Id
- BG001
- value
- 262
- group Id
- BG002
- value
- 251
- group Id
- BG003
- value
- 283
- group Id
- BG004
- value
- 260
- group Id
- BG005
- value
- 1319
- title
- > 1 cm gross disease
- param Type
- NUMBER
- title
- Size of Residual Disease
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle